CMS certification 500058
Kadlec Regional Medical Center
888 Swift Blvd, Richland, WA 99352
Kadlec Regional Medical Center has a CMS overall rating of 4 out of 5 stars. 74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 2. Emergency patients spend a median of 2 h 47 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 512 completed surveys, 20% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | WA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 355 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 47 min | 2 h 31 min | 2 h 42 min |
| Left before being seen Lower is better · 95,054 patients | 6% | 3% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 20 patients | 85% | 62% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 97 patients | 64% | 60% | 65% |
How Kadlec Regional Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Kadlec Regional Medical CenterThis hospital | 4/5 | 74% | 2 h 47 min | 4 better 2 worse |
| Prosser Memorial HospitalSame county · Prosser | 3/5 | 85% | 1 h 52 min | 1 better |
| Trios HealthSame county · Kennewick | 2/5 | 64% | 2 h 47 min | 3 worse |
| Othello Community HospitalSame ZIP area · Othello | Not rated | 64% | — | — |
| Providence St Mary Medical CenterSame ZIP area · Walla Walla | 3/5 | 68% | 2 h 14 min | 3 better |
| Lourdes Medical CenterSame ZIP area · Pasco | 3/5 | 67% | 1 h 57 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Richland.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,050 cases | Too few cases | 3.2% | 3.9% |
| Heart attack 331 cases | Too few cases | 11.6% | 11.9% |
| Heart failure 680 cases | Too few cases | 11.3% | 11.1% |
| Pneumonia 793 cases | Too few cases | 14.3% | 15.2% |
| Stroke 365 cases | Too few cases | 9.4% | 11.9% |
| COPD 182 cases | Too few cases | 10.2% | 8.6% |
| Heart bypass surgery (CABG) 170 cases | Too few cases | 2.8% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1 likely 0.75 – 1.25 | 1 |
| After hip or knee replacement 58 cases | Too few cases | 4.6% | 4.1% |
| Deaths after a serious but treatable surgical complication 139 cases | No different | 177.7 per 1,000 likely 133.09 per 1,000 – 222.31 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 8,719 cases | No different | 0.94 per 1,000 likely 0.4 per 1,000 – 1.48 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 10,252 cases | No different | 0.21 per 1,000 likely 0.03 per 1,000 – 0.4 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 10,511 cases | No different | 0.28 per 1,000 likely 0.1 per 1,000 – 0.46 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,779 cases | No different | 2.52 per 1,000 likely 1.29 per 1,000 – 3.75 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,260 cases | No different | 1.07 per 1,000 likely 0 per 1,000 – 2.46 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,260 cases | No different | 8.57 per 1,000 likely 3.79 per 1,000 – 13.34 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,923 cases | No different | 2.74 per 1,000 likely 1.04 per 1,000 – 4.44 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,232 cases | No different | 4.68 per 1,000 likely 1.55 per 1,000 – 7.8 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 573 cases | No different | 1.48 per 1,000 likely 0.07 per 1,000 – 2.88 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,254 cases | No different | 1.35 per 1,000 likely 0.5 per 1,000 – 2.19 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.65 likely 0.28 – 1.28 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.83 likely 0.41 – 1.53 | 1 |
| Surgical site infections after colon surgery | No different | 1.17 likely 0.61 – 2.03 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.75 likely 0.13 – 2.49 | 1 |
| MRSA bloodstream infections | No different | 0.95 likely 0.3 – 2.29 | 1 |
| C. diff intestinal infections | Better | 0.62 likely 0.4 – 0.91 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 378 cases | Too few cases | 13.8% | 14.4% |
| Readmitted after heart failure 704 cases | Too few cases | 20.3% | 21.3% |
| Readmitted after pneumonia 729 cases | Too few cases | 16.1% | 17.3% |
| Readmitted after COPD 206 cases | Too few cases | 18.7% | 20% |
| Readmitted after heart bypass surgery 122 cases | Too few cases | 10.7% | 11% |
| Readmitted after hip or knee replacement 58 cases | Too few cases | 5.6% | 5.8% |
| Days back in hospital after a heart attack 369 cases | Too few cases | -20.9 days per 100 | — |
| Days back in hospital after heart failure 748 cases | Too few cases | -10.6 days per 100 | — |
| Days back in hospital after pneumonia 783 cases | Too few cases | 11 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 974 cases | No different | 13.6 per 1,000 likely 10.4 per 1,000 – 17.4 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 570 cases | No different | 10.8 per 100 likely 8.5 per 100 – 13.2 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 570 cases | No different | 6 per 100 likely 4.5 per 100 – 7.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,291 cases | No different | 1.1 likely 0.9 – 1.3 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
214 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 36 |
| Emergency Medicine | 22 |
| Physician Assistant | 20 |
| Hospitalist | 14 |
| Anesthesiology | 11 |
| Diagnostic Radiology | 10 |
| Family | 10 |
| Nurse Anesthetist, Certified Registered | 10 |
| Neonatal | 9 |
| Critical Care Medicine | 8 |
| Pediatrics | 7 |
| Pharmacist | 7 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.1M
- 2020 $1.1M
- 2021 $734,700
- 2022 $635,898
- 2023 $532,752
- 2024 $580,679
- 2025 $512,486
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $57,625 | 49 |
| Medical devices and supplies on long-term loan | $1,652 | 5 |
| Honoraria | $1,442 | 1 |
| Debt forgiveness | $779 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Genentech, Inc. | $232,112 | 18 |
| Merck Sharp & Dohme LLC | $91,628 | 6 |
| AstraZeneca Pharmaceuticals LP | $77,218 | 2 |
| Insulet Corporation | $48,275 | 30 |
| Incyte Corporation | $28,000 | 2 |
| Tandem Diabetes Care, Inc. | $9,350 | 19 |
| Abbvie INC. | $7,275 | 1 |
| GlaxoSmithKline, LLC. | $6,895 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| T DM1 Atezolizumab in high risk HER2 patients with residual disease Genentech, Inc. | $119,535 |
| Phase 3 Mosunetuzumab Lenalidomide in R R Follicular Lymphoma Genentech, Inc. | $89,974 |
| A Phase 2 Study to Evaluate Patient Reported Preference for Subcutaneous Pembrolizumab Coformulated with Hyaluronidase MK-3475A Over Intravenous Pemb… Merck Sharp & Dohme LLC | $83,702 |
| SERENA 4 A Randomised Multicentre Double Blind Phase 3 Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrazole plus Palbociclib for the … AstraZeneca Pharmaceuticals LP | $76,218 |
| A Randomized, Double-Blind, Multicenter, Phase 2 Study of Retifanlimab in Combination With INCAGN02385 (Anti-LAG-3) and INCAGN02390 (Anti-TIM-3) as F… Incyte Corporation | $28,000 |
| PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD Genentech, Inc. | $18,960 |
| Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) ABBVIE INC. · NCT05041257 | $7,275 |
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER S GlaxoSmithKline, LLC. | $6,895 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Kadlec Regional Medical Center
Is Kadlec Regional Medical Center a good hospital?
Kadlec Regional Medical Center has a CMS overall rating of 4 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Kadlec Regional Medical Center?
74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 512 completed HCAHPS surveys.
How long is the wait in the Kadlec Regional Medical Center emergency room?
Emergency patients spend a median of 2 h 47 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 6% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Kadlec Regional Medical Center receive money from drug and device companies?
Drug and device makers reported $512,486 in payments to Kadlec Regional Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.